As expected, treatment with MNTX significantly increased 60As6-GFP cell growth in this system (144.0 ± 23.3%, Fig 3C and 3D), indicating that peritoneal mesothelium-derived OGF can also arrest tumor cell growth. The gene discussed is PENK; the disease is neoplasm.